Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Pharmacoeconomics - Open|August 21, 2019
Are Published Health Economic Models for Chronic Hepatitis B Appropriately Capturing the Benefits of HBsAg Loss? A Systematic Literature ReviewPeter Wigfield, Urbano Sbarigia, Mahmoud Hashim, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 13, 2019
Extrapolating Survival Data Using Historical Trial-Based a Priori DistributionsFanni Soikkeli, Mahmoud Hashim, Mario Ouwens, et al.
Cardiology and Therapy|December 14, 2020
Estimating the Gender Distribution of Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy: A Systematic Review and Meta-AnalysisFlorint Kroi, Nils Fischer, Ana Gezin, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 7, 2018
Do Surrogate Endpoints Better Correlate with Overall Survival in Studies That Did Not Allow for Crossover or Reported Balanced Postprogression Treatments? An Application in Advanced Non-Small Cell Lung CancerMahmoud Hashim, Boris M Pfeiffer, Robert Bartsch, et al.
Journal of Comparative Effectiveness Research|September 18, 2020
A comparative network meta-analysis of standard of care treatments in treatment-naïve chronic hepatitis B patientsUrbano Sbarigia, Talitha Vincken, Peter Wigfield, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|September 21, 2020
Challenges in demonstrating the value of disease-modifying therapies for Alzheimer's diseaseAnders Gustavsson, Peter Pemberton-Ross, Melissa Gomez Montero, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 30, 2018
Quality of Life, Glycemic Control, Safety and Tolerability Associated with Liraglutide or Insulin Initiation in Patients with Type 2 Diabetes in Germany: Results from the Prospective, Non-interventional LIBERTY StudyRainer Lundershausen, Sabrina Müller, Mahmoud Hashim, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|November 2, 2019
The cost-effectiveness of metformin in pre-diabetics: a systematic literature review of health economic evaluationsSamron Brhane Gebregergish, Mahmoud Hashim, Bart Heeg, et al.
Reviews in Medical Virology|April 20, 2022
Hepatitis B virus core-related antigen (HBcrAg) as a prognostic marker for the development of hepatocellular carcinoma: A mini systematic review of the literatureAhmed M Afifi, Anas Elgenidy, Mahmoud Hashim, et al.
Retina (Philadelphia, Pa.)|September 8, 2023
A SYSTEMATIC LITERATURE REVIEW OF DISEASE PROGRESSION REPORTED IN RPGR -ASSOCIATED X-LINKED RETINITIS PIGMENTOSAByron L Lam, Hendrik P N Scholl, Daneal Doub, et al.
Pageof 4